Drug Metabolism and Disposition: 23 (2)

February 01, 1995; Volume 23,Issue 2

You have access
Relevance of tissue distribution studies.
K Yeleswaram

Drug Metabolism and Disposition February 1995, 23 (2) 159;
You have access
Chiral sulfoxidation of albendazole by the flavin adenine dinucleotide-containing and cytochrome P450-dependent monooxygenases from rat liver microsomes.
P Moroni, T Buronfosse, C Longin-Sauvageon, P Delatour and E Benoit

Drug Metabolism and Disposition February 1995, 23 (2) 160-165;
You have access
Kinetics of sequential metabolism. Contribution of parallel, primary metabolic pathways to the formation of a common, secondary metabolite.
K S Pang

Drug Metabolism and Disposition February 1995, 23 (2) 166-177;
You have access
Effect of intracellular chloride on the cellular pharmacodynamics of cis-diamminedichloroplatinum(II).
M Jennerwein and P A Andrews

Drug Metabolism and Disposition February 1995, 23 (2) 178-184;
You have access
Metabolism of L-689,502 by rat liver slices to potent HIV-1 protease inhibitors.
S K Balani, S M Pitzenberger, M S Schwartz, H G Ramjit and W J Thompson

Drug Metabolism and Disposition February 1995, 23 (2) 185-189;
You have access
Fetal hepatic propranolol metabolism. Studies in the isolated perfused fetal sheep liver.
J A Ring, H Ghabrial, M S Ching, A Shulkes, R A Smallwood and D J Morgan

Drug Metabolism and Disposition February 1995, 23 (2) 190-196;
You have access
Disposition of ciprofloxacin in the isolated perfused rat liver.
A R Abadìa, L De Francesco and A Guaitani

Drug Metabolism and Disposition February 1995, 23 (2) 197-200;
You have access
Inactivation of constitutive hepatic cytochromes P450 by phencyclidine in the rat.
A Hiratsuka, T Y Chu, E W Distefano, L Y Lin, D A Schmitz and A K Cho

Drug Metabolism and Disposition February 1995, 23 (2) 201-206;
You have access
Biotransformation of losartan to its active carboxylic acid metabolite in human liver microsomes. Role of cytochrome P4502C and 3A subfamily members.
R A Stearns, P K Chakravarty, R Chen and S H Chiu

Drug Metabolism and Disposition February 1995, 23 (2) 207-215;
You have access
Gastrointestinal distribution of the prodrug loperamide oxide and its active drug loperamide in the dog.
L E Van Beijsterveldt, R J Geerts, K Wuyts, R J Woestenborghs, W E Meuldermans and J J Heykants

Drug Metabolism and Disposition February 1995, 23 (2) 216-222;
You have access
Pharmacokinetics and bioavailability of 5-ethyl-2'-deoxyuridine and its novel (5R,6R)-5-bromo-6-ethoxy-5,6-dihydro prodrugs in mice.
A M Cheraghali, R Kumar, E E Knaus and L I Wiebe

Drug Metabolism and Disposition February 1995, 23 (2) 223-226;
You have access
Time- and dose-dependent kinetics of all-trans-retinoic acid in rats after oral or intravenous administration(s).
S el Mansouri, M Tod, M Leclerq, O Petitjean, G Perret and M Porthault

Drug Metabolism and Disposition February 1995, 23 (2) 227-231;
You have access
Metabolism and elimination of oxazepam in F344 rats.
R J Griffin and L T Burka

Drug Metabolism and Disposition February 1995, 23 (2) 232-239;
You have access
Influence of severity of inflammation on the disposition kinetics of propranolol enantiomers in ketoprofen-treated and untreated adjuvant arthritis.
M Piquette-Miller and F Jamali

Drug Metabolism and Disposition February 1995, 23 (2) 240-245;
You have access
Oxidation of 5-aminosalicylic acid by hypochlorous acid to a reactive iminoquinone. Possible role in the treatment of inflammatory bowel diseases.
Z C Liu, R A McClelland and J P Uetrecht

Drug Metabolism and Disposition February 1995, 23 (2) 246-250;
You have access
Role of aldehyde oxidase in the in vitro conversion of famciclovir to penciclovir in human liver.
S E Clarke, A W Harrell and R J Chenery

Drug Metabolism and Disposition February 1995, 23 (2) 251-254;
You have access
Benzoic acid glycine conjugation in the isolated perfused rat kidney.
K Poon and K S Pang

Drug Metabolism and Disposition February 1995, 23 (2) 255-260;
You have access
Oxidation of tolualdehydes to toluic acids catalyzed by cytochrome P450-dependent aldehyde oxygenase in the mouse liver.
K Watanabe, T Matsunaga, I Yamamoto and H Yashimura

Drug Metabolism and Disposition February 1995, 23 (2) 261-265;
You have access
Metabolites of L-735,524, a potent HIV-1 protease inhibitor, in human urine.
S K Balani, B H Arison, L Mathai, L R Kauffman, R R Miller, R A Stearns, I W Chen and J H Lin

Drug Metabolism and Disposition February 1995, 23 (2) 266-270;
You have access
Antipeptide antibodies targeted against specific regions of rat CYP2D1 and human CYP2D6.
E M Laurenzana, S L Sorrels and S M Owens

Drug Metabolism and Disposition February 1995, 23 (2) 271-278;
You have access
Contribution of the small intestine to the first-pass uptake and systemic clearance of propranolol in rabbits.
P Du Souich, H Maurice and L Héroux

Drug Metabolism and Disposition February 1995, 23 (2) 279-284;
You have access
Oxidation of the angiotensin II receptor antagonist losartan (DuP 753) in human liver microsomes. Role of cytochrome P4503A(4) in formation of the active metabolite EXP3174.
C H Yun, H S Lee, H Lee, J K Rho, H G Jeong and F P Guengerich

Drug Metabolism and Disposition February 1995, 23 (2) 285-289;
You have access
Contribution of oxidation and deacetylation to the bioactivation of acetaminophen in vitro in liver and kidney from male and female Sprague-Dawley rats.
C A Mugford and J B Tarloff

Drug Metabolism and Disposition February 1995, 23 (2) 290-294;
You have access
Comparison of acetyl coenzyme A:arylamine N-acetyltransferase activity in the liver, kidney, and intestine of male and female rats from three strains.
J A Ware, P Divakaruni and C K Svensson

Drug Metabolism and Disposition February 1995, 23 (2) 295-297;

Main menu

User menu

Search

Table of Contents

In this issue

Navigate

More Information

ASPET's Other Journals